90 related articles for article (PubMed ID: 593833)
1. [The course of hydatidiform moles, followed by the radio-immunological estimation of choriogonadotrophin (author's transl)].
Roger M; Gauthier J; Feinstein-Soldat MC; Tardy J; Scholler R
Nouv Presse Med; 1977 Oct; 6(33):2967-71. PubMed ID: 593833
[TBL] [Abstract][Full Text] [Related]
2. [Biological criteria for the surveillance of hydatidiform moles and choriocarcinomas].
Roger M; Feinstein-Soldat MC; Emmanuel J; Scholler R
J Gynecol Obstet Biol Reprod (Paris); 1977 Mar; 6(2):207-25. PubMed ID: 886170
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
4. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
6. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
7. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
8. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
9. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
Mundangepfupfu T; Waseem M
J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
[TBL] [Abstract][Full Text] [Related]
10. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues.
Yoshimura M; Pekary AE; Pang XP; Berg L; Goodwin TM; Hershman JM
J Clin Endocrinol Metab; 1994 Apr; 78(4):862-6. PubMed ID: 8157712
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
Delvoye P; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
14. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
15. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
16. [Early diagnosis of molar pregnancy by measuring AFP and HCG in serum (author's transl)].
Dericks-Tan JS; Taubert HD
Geburtshilfe Frauenheilkd; 1980 Oct; 40(10):933-5. PubMed ID: 6160078
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the heterogeneity of urinary HCG molecules by RRA and RIA (author's transl)].
Kushiki N; Fuzishima K; Kinoshita T; Ino H; Naka O
Nihon Naibunpi Gakkai Zasshi; 1979 Sep; 55(9):1076-88. PubMed ID: 227758
[TBL] [Abstract][Full Text] [Related]
19. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
Lichtenegger W; Weiss PA
Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin levels in complete and partial hydatidiform moles and in nonmolar abortuses.
Smith EB; Szulman AE; Hinshaw W; Tyrey L; Surti U; Hammond CB
Am J Obstet Gynecol; 1984 May; 149(2):129-32. PubMed ID: 6720790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
